Federal Register of Legislation - Australian Government

Primary content

Regulations as made
This instrument amends the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2009 to set out the cost recovery fees that apply from 1 July 2021 for applications requesting listing on the Pharmaceutical Benefits Scheme or National Immunisation Program.
Administered by: Health
Registered 04 May 2021
Tabling HistoryDate
Tabled HR11-May-2021
Tabled Senate11-May-2021
To be repealed 12 Aug 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2021

I, General the Honourable David Hurley AC DSC (Retd), Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulations.

Dated 29 April 2021

David Hurley

Governor‑General

By His Excellency’s Command

Greg Hunt

Minister for Health and Aged Care

 

 

 

  

  


Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2009          2

 


1  Name

                   This instrument is the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2021.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 July 2021.

1 July 2021

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

  

National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2009

1  Subregulation 1A.1(2)

Omit “$180,960”, substitute “$181,500”.

2  Subregulation 1A.2(3)

Omit “$103,270”, substitute “$103,560”.

3  Regulation 1A.7 (table item 1)

Omit “15,580”, substitute “15,700”.

4  Regulation 1A.7 (table item 2)

Omit “21,180”, substitute “21,350”.

5  Subregulation 2.2(1) (table item 1, column 2)

Omit “223,340”, substitute “225,120”.

6  Subregulation 2.2(1) (table item 2, column 2)

Omit “168,700”, substitute “170,050”.

7  Subregulation 2.2(1) (table item 3, column 2)

Omit “43,020”, substitute “43,360”.

8  Subregulation 2.2(1) (table item 4, column 2)

Omit “33,710”, substitute “33,980”.

9  Subregulation 2.2(1) (table item 5, column 2)

Omit “12,730”, substitute “12,270”.

10  Subregulation 2.2(1) (table item 6, column 2)

Omit “6,450”, substitute “6,500”.

11  Subregulation 2.2(1) (table item 7, column 2)

Omit “166,650”, substitute “167,980”.

12  Subregulation 2.2(1) (table item 8, column 2)

Omit “41,680”, substitute “42,010”.

13  Subregulation 2.2(1) (table item 9, column 2)

Omit “41,830”, substitute “42,160”.

14  Subregulation 2.2(1) (table item 10, column 2)

Omit “238,660”, substitute “240,570”.

15  Subregulation 2.7(2) (heading)

After “listed drugs”, insert “, medicinal preparations”.

16  Paragraph 2.7(2)(b)

After “listed drug”, insert “, medicinal preparation”.

17  Subregulation 3.3(1) (table item 1)

Omit “141,410”, substitute “142,540”.

18  Subregulation 3.3(1) (table item 2)

Omit “111,920”, substitute “112,810”.

19  Subregulation 3.3(1) (table item 3)

Omit “74,090”, substitute “74,680”.

20  Subregulation 3.3(1) (table item 4)

Omit “20,300”, substitute “20,460”.

21  Subregulation 3.3(1) (table item 5)

Omit “13,170”, substitute “12,690”.

22  Paragraph 3.3(3)(a)

Omit “$133,135”, substitute “$134,200”.

23  Paragraph 3.3(3)(b)

Omit “$103,645”, substitute “$104,470”.

24  Paragraph 3.3(3)(c)

Omit “$65,815”, substitute “$66,340”.

25  Subregulation 3A.1(1) (table item 1)

Omit “5,040”, substitute “5,080”.

26  Subregulation 3A.1(1) (table item 2)

Omit “1,970”, substitute “1,980”.

27  Subregulation 3A.1(1) (table item 3)

Omit “10,330”, substitute “10,410”.

28  Subregulation 3A.1(1) (table item 4)

Omit “7,040”, substitute “7,090”.

29  Subregulation 3A.5(2)

Omit “$8,275”, substitute “$8,340”.

30  In the appropriate position in Part 7

Insert:

Division 5Application provisions relating to amendments commencing on 1 July 2021

7.14  Application provision for the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2021

                   The amendments of these Regulations made by the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2021 apply in relation to applications, notification for which is given on or after 1 July 2021.